1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality—a national cohort study
(
- Contribution to journal › Article
-
Mark
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs : a Swedish nationwide study (COVID-19-REUMA)
(
- Contribution to journal › Article
- 2023
-
Mark
The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)
(
- Contribution to journal › Article
-
Mark
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2020
-
Mark
Autoantibody and cytokine profiles during treatment with belimumab in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2019
-
Mark
Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
- 2018
-
Mark
Smoking reduces the efficacy of belimumab in mucocutaneous lupus
(
- Contribution to journal › Article
- 2017
-
Mark
Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus
(
- Contribution to journal › Article